Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.017
%
-3,23%
Latest
0.509
High
0.525
Low
0.488
Volume
677 993
Turnover (SEK)
342 190
Market Value (MSEK)
148,8
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Niklas Prager

Board

  • Anna Törner
  • Kristina Drott
  • Peter Buhl

Videos